These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 12894558

  • 1. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C, Wellham LL.
    Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C, Calabretta B.
    Cancer Res; 1996 Oct 01; 56(19):4332-7. PubMed ID: 8813118
    [Abstract] [Full Text] [Related]

  • 3. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May 01; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 4. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L, Tong Y, Jin Y, Zhou S, Zhang Y, Yang X, Mao N.
    Chin Med J (Engl); 2001 Sep 01; 114(9):929-32. PubMed ID: 11780384
    [Abstract] [Full Text] [Related]

  • 5. Overcoming multidrug resistance in human carcinoma cells by an antisense oligodeoxynucleotide--doxorubicin conjugate in vitro and in vivo.
    Ren Y, Wang Y, Zhang Y, Wei D.
    Mol Pharm; 2008 Sep 01; 5(4):579-87. PubMed ID: 18461970
    [Abstract] [Full Text] [Related]

  • 6. Modulation of multidrug-resistance-associated P-glycoprotein in human U-87 MG and HUV-ECC cells with antisense oligodeoxynucleotides to MDR1 mRNA.
    Rittierodt M, Tschernig T, Harada K.
    Pathobiology; 2004 Sep 01; 71(3):123-8. PubMed ID: 15051924
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance.
    Quattrone A, Papucci L, Morganti M, Coronnello M, Mini E, Mazzei T, Colonna FP, Garbesi A, Capaccioli S.
    Oncol Res; 1994 Sep 01; 6(7):311-20. PubMed ID: 7865906
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of P-glycoprotein and increasing of drug-sensitivity of a human carcinoma cell line (KB-A-1) by an antisense oligodeoxynucleotide-doxorubicin conjugate in vitro.
    Ren Y, Wei D, Zhan X.
    Biotechnol Appl Biochem; 2005 Apr 01; 41(Pt 2):137-43. PubMed ID: 15202936
    [Abstract] [Full Text] [Related]

  • 9. An oligomer complementary to the 5' end region of MDR1 gene decreases resistance to doxorubicin of human adenocarcinoma-resistant cells.
    Corrias MV, Tonini GP.
    Anticancer Res; 1992 Apr 01; 12(5):1431-8. PubMed ID: 1444203
    [Abstract] [Full Text] [Related]

  • 10. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y, Qian F, Wei D, Liu J.
    J Pharm Pharmacol; 2004 Oct 01; 56(10):1307-14. PubMed ID: 15482646
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
    Jin J, Wang FP, Wei H, Liu G.
    Cancer Chemother Pharmacol; 2005 Feb 01; 55(2):179-88. PubMed ID: 15378274
    [Abstract] [Full Text] [Related]

  • 13. Treatment of multidrug-resistant murine leukemia with antisense mdr1 oligodeoxynucleotides.
    Hiratake S, Azuma E, Nishiguchi Y, Nagai M, Ido M, Komada Y, Sakurai M.
    Biomed Pharmacother; 1997 Feb 01; 51(6-7):276-83. PubMed ID: 9309248
    [Abstract] [Full Text] [Related]

  • 14. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells.
    Gao P, Zhou GY, Lei DP, Zhang XF, Li L, Xu JW, Lin XY.
    Cytotherapy; 2007 Feb 01; 9(8):795-801. PubMed ID: 17917879
    [Abstract] [Full Text] [Related]

  • 15. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
    Green DW, Roh H, Pippin JA, Drebin JA.
    J Surg Res; 2001 Nov 01; 101(1):16-20. PubMed ID: 11676549
    [Abstract] [Full Text] [Related]

  • 16. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B, Ye T, Zhao L, Li DH, Gou XH, Zhao LY, Han L, Chen L, Yan LN, Gong JP.
    Hepatobiliary Pancreat Dis Int; 2006 Nov 01; 5(4):552-9. PubMed ID: 17085341
    [Abstract] [Full Text] [Related]

  • 17. A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line.
    Bhat UG, Winter MA, Pearce HL, Beck WT.
    Mol Pharmacol; 1995 Oct 01; 48(4):682-9. PubMed ID: 7476894
    [Abstract] [Full Text] [Related]

  • 18. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.
    Chou TC, Guan Y, Soenen DR, Danishefsky SJ, Boger DL.
    Cancer Chemother Pharmacol; 2005 Oct 01; 56(4):379-90. PubMed ID: 15875185
    [Abstract] [Full Text] [Related]

  • 19. Inhibition growth of multidrug resistant KBV200 cells by MDR1 antisense RNA.
    Li Y, Wang Y.
    Biochem Biophys Res Commun; 1997 Oct 09; 239(1):345-8. PubMed ID: 9345322
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.